Atlas Trials

To Evaluate the Efficacy and Safety of LIZTOX in Subjects with Benign Masseteric Hypertrophy

Clinical trial NCT05964257 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05964257
Sponsor
Huons Biopharma
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Benign Masseteric Hypertrophy
Start date
2023-07-25
Primary completion
2024-03-07
Enrollment
188

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.